An α-particle emitting antibody ([213Bi]J591) for radioimmmunotherapy of prostate cancer

D. J. George, M. R. McDevitt, E. Barendswaard, D. Ma, L. Lai, M. J. Curcio, G. Sgouros, A. M. Ballangrud, W. H. Yang, R. D. Finn, V. Pellegrini, Jr Geerlings, M. Lee, M. W. Brechbiel, N. H. Bander, C. Cordon-Cardo, D. A. Scheinberg

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)1
Number of pages1
JournalProstate Journal
Volume3
Issue number1
DOIs
StatePublished - 2001

ASJC Scopus subject areas

  • Oncology
  • Urology
  • Cancer Research

Cite this

George, D. J., McDevitt, M. R., Barendswaard, E., Ma, D., Lai, L., Curcio, M. J., Sgouros, G., Ballangrud, A. M., Yang, W. H., Finn, R. D., Pellegrini, V., Geerlings, J., Lee, M., Brechbiel, M. W., Bander, N. H., Cordon-Cardo, C., & Scheinberg, D. A. (2001). An α-particle emitting antibody ([213Bi]J591) for radioimmmunotherapy of prostate cancer. Prostate Journal, 3(1), 1. https://doi.org/10.1046/j.1525-1411.2001.003001001.x